Welcome to the first participants on the RADAR Study" /> Welcome to the first participants on the RADAR Study" />
The NICRF welcomes the first participants of the RADAR Study: Reducing Pathology in Alzheimer’s Disease Through Angiotensis Targeting. The RADAR Trial
Dr Bernadette McGuinness, Principal Investigator within the Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, QUB, is undertaking a Phase II, randomised, double-blind, placebo-control trial to evaluate the effect of Losartan on brain tissue in patients diagnosed with Alzheimer’s Disease.
Read more about the Study here.
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11